
Prof @UIllinoisLaw, @IllinoisMed, @IGBIllinois, @eucenter; also @CeBIL_Center #patents, #IP, #biotech, #pharma, #bioethics. Ducks, drugs, and nicks that roll.
Champaign, IL
Joined August 2012
- Tweets14.2K
- Following284
- Followers4.6K
- Likes2.8K
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
1/ OK, everyone, buckle up. @RESachs and I have a piece @TheAtlantic about Aduhelm.
It's about how the law links FDA approval to payment policy, which means we're likely to spend through the nose for a drug that may not work.
theatlantic.com/ideas/archiv…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
The FDA's approval of Aduhelm is a big fucking deal, and not in a good way, as @RESachs explains here: healthaffairs.org/do/10.1377…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
Everything you need to know about when you could get a Covid-19 vaccine and how, by @Loftus and @betswrites wsj.com/articles/the-covid-1…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
.@PennMedicine scientist Drew Weissman talked to @CNN's @drsanjaygupta about how the mRNA tech he developed at Penn will help save the world from #COVID19 and revolutionize medicine cnn.it/2HBlmDR
Not my area but a really interesting online symposium:
Check out @UChiLRev's online symposium on COVID-19 and Criminal Justice featuring essays by Professors @SharonDolovich, @valenabeety, @ProfPamMetzger and @jenndoliva! buff.ly/2KpjGhB #WomenAlsoKnowLaw
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
Perspectives on Biohackers and DIY CRISPR ipscell.com/2020/11/perspect…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
Always read @RESachs on drug pricing proposals.
healthaffairs.org/do/10.1377…
As we approach Thanksgiving, just wanted to give thanks to everyone at @HarvardEthics for the incredible year last year. Miss you all! Hope we can see each other again, soon.
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
A third Covid-19 vaccine, this one developed by AstraZeneca and the University of Oxford, was found to be effective. @jennystrasburg reports this candidate was as much as 90% effective depending on the dosing. wsj.com/articles/astrazeneca…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
Mark your calendars for Dec. 10. Pfizer meets VRBPAC fda.gov/news-events/press-an…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
We have scheduled a meeting of our Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10th to discuss an emergency use authorization request for a #COVID19 vaccine. fda.gov/news-events/press-an…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
If this external VRBPAC review of the 1st vaccine goes well, we'll likely see Phase 1a distribution begin right after December 10th
fda.gov/news-events/press-an…
nap.edu/download/25917
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
In the spring, everyone said it would take 12 to 18 months for a vaccine. Here’s the improbable tale of how Moderna, Pfizer, BioNTech and a massive federal effort drastically shortened that timeline. nytimes.com/2020/11/21/us/po…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
Covid-19 antibody drug from Regeneron is authorized by @US_FDA, the second such antibody drug to gain clearance. Story coming to @WSJ... fda.gov/news-events/press-an…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
🦆 ALL HAIL LONG BOI 🦆
The final results:
Long Boi - 2,182
Lancaster Ducks - 2,090
SWANsea Swans - 1,048
Cath the OU Duck - 774
See the full table at bantshire.github.io/ranking-…
How should #innovation policymakers think about #AI—and its biases—in addressing #COVID? A new WD Post from @WNicholsonPrice, @RESachs, me & @PatentScholar writtendescription.blogspot.…
Jacob S. Sherkow (@jsherkow@mastodon.lawprofs.org) retweeted
Check out this excellent tweet thread on public funding of drug innovation!
This Post is from an account that no longer exists. Learn more
WOOOOOOOT!
The drug maker Pfizer and its German partner BioNTech said Friday afternoon they have applied to the FDA for an emergency use authorization for their Covid-19 vaccine. buff.ly/36VniiV
#Pfizer #BioNTech #COVID19 #vaccine




















